NEW YORK – Researchers at the Colorado Center for Personalized Medicine's (CCPM) Biobank are collecting patient samples in order to analyze genetic data using SNP microarrays to provide pharmacogenetic (PGx) results.
The CCPM has begun returning PGx test results to program participants, and will eventually deliver disease risk and carrier screening results.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
